Tenders/T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services

T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services

Division of Purchase and Property

Published: Aug 19, 2026

Updated: Aug 20, 2026

About This Opportunity

This is a services contract in the general supplies sector, with a focus on General Supplies. Located in United States, North America, this opportunity is open to firms and consortiums.

Published through NJ NJSTART, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the general supplies sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, originating from the United States and managed via the njstart_nj platform, focuses on the procurement of a critical medical supply. The title, 'T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services', clearly defines the product and its intended use. The contracting authority is the Division of Purchase and Property. Naloxone is an essential medication used to rapidly reverse opioid overdose. The requirement for an 'FDA-Approved' product underscores the critical importance of quality, safety, and efficacy. This procurement aims to ensure the availability of this life-saving medication for distribution and use by the Department of Human Services and potentially other state agencies or partners addressing the opioid crisis. Typical requirements for such tenders include verified FDA approval, specific dosage and formulation (4mg nasal spray), packaging integrity, and stringent supply chain security to prevent diversion. Bidders must demonstrate their ability to supply large quantities reliably and maintain appropriate storage and handling conditions. Evaluation criteria will likely prioritize product authenticity, supplier reliability, compliance with all regulatory requirements, and competitive pricing. This tender is a key component of public health initiatives in New Jersey.

Data provenance

This notice is sourced from NJ NJSTART and was originally published on August 19, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Division of Purchase and Property

Division of Purchase and Property has issued 54 procurement notices on BidsFactory, including 18 currently open and 0 awarded contracts. Activity concentrates in Governance & Public Administration, General Supplies & Services, and Health & Medical. All notices are published for United States. Notices are distributed via NJ NJSTART. Most recent publication: August 19, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit NJ NJSTART to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Division of Purchase and Property in United States. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Services contract in the General Supplies & Services sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in United States. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.